Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors.
about
Three-Dimensional Patient-Derived In Vitro Sarcoma Models: Promising Tools for Improving Clinical Tumor Management.Models of Models: A Translational Route for Cancer Treatment and Drug Development.CMScaller: an R package for consensus molecular subtyping of colorectal cancer pre-clinical models.Screening drug effects in patient-derived cancer cells links organoid responses to genome alterations.Consensus molecular subtypes of colorectal cancer are recapitulated in in vitro and in vivo models.Opportunities for organoids as new models of aging.Characterization of genetic intratumor heterogeneity in colorectal cancer and matching patient-derived spheroid cultures.G protein-coupled receptor GPR55 promotes colorectal cancer and has opposing effects to cannabinoid receptor 1.Patient-derived organoid models help define personalized management of gastrointestinal cancer.Functional significance and therapeutic implication of ring-type E3 ligases in colorectal cancer.From Chemotherapy to Combined Targeted Therapeutics: In Vitro and in Vivo Models to Decipher Intra-tumor Heterogeneity.New tools for old drugs: Functional genetic screens to optimize current chemotherapy.Gastroenteropancreatic neuroendocrine neoplasms: genes, therapies and models.Esophageal 3D Culture Systems as Modeling Tools in Esophageal Epithelial Pathobiology and Personalized Medicine.Exploring the OncoGenomic Landscape of cancerPrediction of Target Genes and Pathways Associated With Cetuximab Insensitivity in Colorectal CancerOrganoid technology and applications in cancer research
P2860
Q41684395-2BF3E0BE-2695-45DA-A56A-244990A2E6C8Q41833969-E3E6EC0F-9AF5-433C-AF25-4310018E9FA2Q47104672-D8F646A1-D53D-49B4-A5C9-68D20FA53C15Q47143099-6496C690-757D-46D8-99F2-14E45D37C674Q47203432-9A6BEFC8-9723-47EF-B2E7-A3215FE9BC77Q47562383-69DBC3A6-4A3F-414D-9BD9-9945698092C4Q47609470-ADD02D68-9E55-450D-9AE3-F959C94A1DBBQ47850555-D3A36C08-FEAF-4812-9BE7-91E48CFCDB3FQ50010294-AE8755E3-A31C-4DF2-8C41-2E5175196790Q50026061-90A91B41-0506-47FA-9736-7AC34080A080Q50351390-19C33C73-F6C1-444F-8404-CD2803190572Q52430564-A57E4237-084F-41BA-ABEF-7CF4D9AEA158Q52625303-5161D541-E1E4-49EF-90A5-FE7063755AA0Q52715285-B1ABF77F-7D31-4059-8D9A-CF6B09D0F559Q57975115-83C6DA3E-9ABE-4D46-9C24-D640D389C8D6Q58583964-4915AFC4-DBED-4E92-96C9-AAD5D72C7CD3Q58737628-430989B4-AC51-447A-93A5-8F580F250BFD
P2860
Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 February 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular dissection of colore ...... ensitivity to EGFR inhibitors.
@en
Molecular dissection of colore ...... ensitivity to EGFR inhibitors.
@nl
type
label
Molecular dissection of colore ...... ensitivity to EGFR inhibitors.
@en
Molecular dissection of colore ...... ensitivity to EGFR inhibitors.
@nl
prefLabel
Molecular dissection of colore ...... ensitivity to EGFR inhibitors.
@en
Molecular dissection of colore ...... ensitivity to EGFR inhibitors.
@nl
P2093
P2860
P50
P356
P1476
Molecular dissection of colore ...... sensitivity to EGFR inhibitors
@en
P2093
Alberto Fusi
Bodo Lange
Caroline Schweiger
Christoph Reinhard
Christoph Wierling
David Henderson
Dirk Wienke
Hans-Jörg Warnatz
Inge Kehler
Jens Hoffmann
P2860
P2888
P356
10.1038/NCOMMS14262
P407
P50
P577
2017-02-10T00:00:00Z